ArticlePDF Available

Residual volatile anesthetics after workstation preparation and activated charcoal filtration

Authors:

Abstract

Background: Volatile anesthetics potentially trigger malignant hyperthermia crises in susceptible patients. We therefore aimed to identify preparation procedures for the Draeger Primus that minimize residual concentrations of desflurane and sevoflurane with and without activated charcoal filtration. Methods: A Draeger Primus test workstation was primed with 7% desflurane or 2.5% sevoflurane for 2 hours. Residual anesthetic concentrations were evaluated with five preparation procedures, three fresh gas flow rates, and three distinct applications of activated charcoal filters. Finally, non-exchangeable and autoclaved parts of the workstation were tested for residual emission of volatile anesthetics. Concentrations were measured by multicapillary column - ion mobility spectrometry with limits of detection/quantification being <1 part per billion (ppb) for desflurane and <2.5ppb for sevoflurane. Residual volatile anesthetic concentrations <5ppm were assumed to be save. Results: The best preparation procedure included a flushing period of 10 minutes between removal and replacement of all parts of the ventilator circuit which immediately produced residual concentrations <5ppm. A fresh gas flow of 10L/min reduced residual concentration as effectively as 18L/min, whereas flows of 1 or 5L/min slowed washout. Use of activated charcoal filters immediately reduced and maintained residual concentrations <5ppm for up to 24 hours irrespective of previous workstation preparation. The fresh gas hose, circle system, and ventilator diaphragm emitted traces of volatile anesthetics. Conclusion: In elective cases, presumably safe concentrations can be obtained by a 10-minute flush at ≥10L/min between removal and replacement all components of the airway circuit. For emergencies, we recommend using an activated charcoal filter.
Acta Anaesthesiol Scand. 2020;00:1–7.
|
  1wileyonlinelibrary.com/journal/aas
Received: 7 Januar y 2020 
|
  Revised: 19 Febr uary 2020 
|
  Accepted: 27 Februar y 2020
DOI : 10.1111/aas.135 71
ORIGINAL ARTICLE
Residual volatile anesthetics after workstation preparation and
activated charcoal filtration
Lukas M. Müller-Wirtz1| Christine Godsch1| Daniel I. Sessler2| Thomas Volk1|
Sascha Kreuer1| Tobias Hüppe1
This is an op en access arti cle under the ter ms of the Creative Commons Attribution L icense, which pe rmits use, dis tribu tion and reprod uction in any med ium,
provide d the original wor k is properly cited.
© 2020 The Authors. Acta Anaesthesiologica Scandinavica published by John Wil ey & Sons Ltd on behalf of Acta A naesthesio logica Scand inavic a Foundation
The Cent er of Breath Rese arch is part of th e Outcomes Rese arch Consort ium, Clevelan d, OH, USA
1Center of Breath Research, Depar tment
of Anesthesiology, Intensive Care and
Pain The rapy, Saar land Uni versit y Medical
Center, Homburg, Saarlan d, Germany
2Depar tment of Outcomes Resea rch,
Anest hesiology Institute, Cleveland Clinic,
Cleveland, OH, USA
Correspondence
Lukas M. Müller-Wirtz, CBR-Center
of Breath Research, Department of
Anest hesiology, Intensive Care and Pain
Therapy, Saarlan d Univer sity Medical Center
and Saar land University Faculty of Medicine,
Hombur g, Saar land 66 421, Ger many.
Email: lukas.wirtz@uks.eu
Funding information
The act ivated charcoal filter s were provided
by Medical Instrument s Corp oration
GmbH, G ermany. All other materials were
provide d solely from ins titut ional an d/or
departmental sources.
Background: Volatile anesthetics potentially trigger malignant hyper thermia crises in
susceptible patients. We therefore aimed to identify preparation procedures for the
Draeger Primus that minimize residual concentrations of desflurane and sevoflurane
with and without activated charcoal filtration.
Methods: A Draeger Primus test workstation was primed with 7% desflurane or 2.5%
sevoflurane for 2 hours. Residual anesthetic concentrations were evaluated with five
preparation procedures, three fresh gas flow rates, and three distinct applications of
activated charcoal filters. Finally, non-exchangeable and autoclaved parts of the work-
station were tested for residual emission of volatile anesthetics. Concentrations were
measured by multicapillary column–ion mobility spectrometry with limits of detection/
qu a n t i f i c at i o n being <1 pa r t pe r bi llion (ppb) fo r de s f l u r a n e an d <2.5 ppb fo r se voflurane.
Results: The best preparation procedure included a flushing period of 10 minutes
between removal and replacement of all parts of the ventilator circuit which imme-
diately produced residual concentrations <5 ppm. A fresh gas flow of 10 L/minute
reduced residual concentration as effectively as 18 L/minute, whereas flows of 1 or
5 L/minute slowed washout. Use of activated charcoal filters immediately reduced
and maintained residual concentrations <5 ppm for up to 24 hours irrespective of
previous workstation preparation. The fresh gas hose, circle system, and ventilator
diaphragm emitted traces of volatile anesthetics.
Conclusion: In elective cases, presumably safe concentrations can be obtained by a
10-minute flush at ≥10 L/minute between removal and replacement all components of
the airway circuit. For emergencies, we recommend using an activated charcoal filter.
1 | INTRODUCTION
Malignant hyperthermia is rare and susceptible patients need spe-
cific anesthetic management.1 Volatile anesthetics are well-known
triggering agents, so exposure should be avoided.2,3 Anesthesia
workstations regularly used with volatile anesthetics can emit
potentially triggering residual concentrations of volatile anesthet-
ics. The Malignant Hyperthermia Association of the United States
(MHAUS)4 and the European Malignant Hyperthermia Group
(EMHG)5 recommend three possible options to use anesthesia work-
stations to provide “trigger-free” anesthesia. The first option is to
use a “vapor-free” workstation—a workstation that has never been
2 
|
   MÜLLER-WIRT Z ET aL.
exposed to volatile anesthetics. The second option is the prepara-
tion of a workstation by the replacement of exchangeable parts of the
breathing circuit and flushing. And the third option is to use activated
charcoal filters.
Gi ven the co st of mod e rn an e sth e si a wor k stat ion s and the ra r ity of
malign an t hy per the rmia, it is usually imp rac tic al to re ser ve a dedica te d
“vapor-free” workstation. Thus, workstation preparation and flushing
are often performed. A most probably safe threshold of 5 parts per
million (ppm) was established based on expert opinions and a single
study performed in swine.6 So previous studies assessing the prepa-
ration of the Draeger Primus reported their results down to 5 ppm.7-9
We use the far more accurate technique of multicapillary column–ion
mobility spectrometry (MCC-IMS) which detects volatile anesthetics
down to concentrations of several parts per billion (ppb),10 thereby
allowing us to reliably distinguish residual anesthetic concentrations
after various preparation methods and identify the best.
We also evaluated activated charcoal filters.11 There is compel-
ling evidence that these filters effectively absorb volatile anesthet-
ics.11,12 However, published studies did not evaluate positioning a
sin gl e fi lter close to the patie nt wit ho ut a rep la ceme nt of the breath-
ing circuit which might save time in emergenc y situations.
At least non-exchangeable and non-disposable components of
the anesthesia workstation are apparently major sources of resid-
ual concentrations. Inert coating of the inner surface of a fresh gas
hose may reduce, but not totally exclude, absorbance and emission
of volatile anesthetics. Furthermore, it is unclear, whether autoclav-
ing completely eliminates the emission of residual concentrations.
We therefore investigated the ef fectiveness of Draeger Primus
machine component replacement, various fresh gas flows, and dif-
ferent applications of activated charcoal filters on residual concen-
trations of desflurane and sevoflurane, and finally investigated the
emission of residual concentrations by non-exchangeable and auto-
claved parts.
2 | MATERIAL AND METHODS
An anesthesia workstation (Primus, Draeger) was used with match-
ing accessories (breathing tubes: Draeger Anesthesia set VentStar®,
disposable, basic, 2 L, 1.8 m/1.5 m, latex-free; carbon dioxide absorber:
Draeger CLIC Abso rber 80 0+; test lung : Draeger SelfTestLung™; sam-
ple tube and water trap of the capnography: Draeger Waterlock® 2
and sample tube; heat and moisture exchanger: Gibeck Humid-Vent®).
The workstation was primed by ventilating a test lung with desflurane
(7%) or sevoflurane (2.5%) for two hours at a fresh gas flow of 1 L/
minute (100% oxygen). Ventilatory parameters were as follows: tidal
volume = 500 mL, ventilation frequency = 12/minute, PEEP 5 mbar.
Gas sampling was started within a maximum of 30 seconds
after preparation from the inspiratory limb of the workstation
and repeated at 5-minute intervals (sampling position 1, Figure 1).
The concentrations of desflurane and sevoflurane were mea-
sured by multicapillar y column–ion mobility spectrometry (MCC-
IMS by B&S Analytik, Dortmund, Germany). Visual Now 3.6 (B&S
Analytik) software was used to quantify peak intensity in volts.
Defined standards of desflurane and sevoflurane ranging from 1 to
7000 ppb (0.001 to 7 ppm) were used for calibration. Limits of de-
tection and limits of quantification were determined as previously
described by Maurer et al.13 Limit of detection/quantification was
0.8/0.9 ppb (0.0008/0.0009 ppm) for desflurane, and 2.2/2.4 ppb
(0.0022/0.0024 ppm) for sevoflurane.
2.1 | Assessment of different preparation
procedures and fresh gas flow rates
After priming, the vaporizer was removed, and the fresh gas flow
was set to 18 L/minute until the detection limit of the internal optical
Editorial Comment
This investigation presents a detailed description for how
one can minimize residual concentrations of desflurane
and sevoflurane to a safe level if the anesthesia worksta-
tion must be mad e ra pi dl y re ady for a malign an t hy pe rth er-
mia-susceptible patient. The simplest and quickest method
is to place an activated charcoal filter at the Y-piece.
FIGURE 1 Experimental setup during measurement period. Residual concentrations were measured at sampling position 1 to evaluate different
preparation procedures, dif ferent rates of fresh gas flow and activated charcoal filters at filter position 1. Sampling position 2 was only used for the
assessment of one activated charcoal filter at the y-piece (filter position 2). exp./insp., expiratory/inspirator y limb of the circle system; HME, heat
and moisture exchanger; MCC-IMS, multicapillary column–ion mobility spectrometer [Colour figure can be viewed at wileyonlinelibrary.com]
  
|
 3
MÜLLER-WIRT Z ET aL.
sensors was reached (approximately 90 seconds). The respective
preparation procedure was subsequently performed (Table 1). After
each preparation procedure, a compliance and leak test was carried
out. The sample tube of the MCC-IMS was connected to the inspira-
tory limb by a t-piece and measurements were starte d (sampling posi-
tion 1, Figure 1). During the measurement period, fresh gas flow was
set to 18 L/minute and a new test lung was ventilated with the same
ventilatory settings used for priming. Each preparation procedure was
test ed th re e tim es for 10 0 0 mi nutes . Fin ally, th e bes t pre pa r at ion pro -
cedure was evaluated once with each fresh gas flow of 1, 5, and 10 L/
minute. Experimental setup, priming, and preparation remained the
same.
2.2 | Assessment of activated charcoal filters
Priming of the workstation was done as already described above. A
fresh gas flow of 10 L/minute, a new heat and moisture exchanger
and a new test lung was used during the measurement period. Three
different filter applications (Vapor-Clean, Dynasthetics) were as-
sessed, each with desflurane and sevoflurane.
1. The best tested preparation was combined with the additional
placement of activated charcoal filters at the inspirator y and
expiratory limb of the circle system (filter position 1, sampling
position 1, Figure 1).
2. Filter application was performed according to the manufac turer's
recommendations, which includes replacement of the breathing
tubes, breathing bag and the placement of activated charcoal
filters at the inspiratory and expiratory limb of the circle system
(filter position 1, sampling position 1, Figure 1).
3. Only one filter was placed at the y-piece of the breathing tubes
without other changes to the breathing circuit than the heat and
moisture filter. The t-piece for sampling was therefore moved
from the inspiratory limb of the circle system to the test lung (fil-
ter position 2, sampling position 2, Figure 1).
Compliance and leak test was omitted during the second and
third method, as these approaches were designed for emergency
use when time is limited.
2.3 | Assessment of trace concentrations emitted by
different parts of the workstation
Our local technician provided a used fresh gas hose removed dur-
ing inspection of a Draeger Primus. The inner diameter was 6 mm
with a leng th of 70 cm resulting in a volume of approximately 20 mL
and a surface area of 130 cm2. The circle system and ventilator dia-
phragm were cleaned according to the local hygiene protocol (1-hour
thermodesinfector, minimum exposure time to 93.7°C of 5 minutes;
autoclaving at 134°C). Fresh gas hose and ventilator diaphragm
were placed in a perfluoroalkoxy alkane container (2.7 L) at 20°C.
The container was flushed with purified air (ALPHAGAZ™ 1 LUFT,
Air Liquide) for two minutes and repeated headspace samples were
subsequently taken by MCC-IMS over one hour. The circle system
was investigated by taking samples from the inspiratory limb placed
in a climatized room at 20°C over one hour. The highest measured
concentration was taken as the emitted concentration.
2.4 | Statistics
Statistics were calculated with SigmaPlot 12.5 (Systat Software
GmbH). Data are presented as means ± SDs. After testing for nor-
mality by Shapiro-Wilk test, comparisons were performed by a one-
way ANOVA followed by multiple comparisons with Bonferroni
correction. P < .05 was considered as statistically significant.
Washout curves were fitted by nonlinear regression to appropriate
mathematical functions.
3 | RESULTS
Initial tests before finalization of the study design showed that
ventilation of a test lung is critical to allow a sufficient washout.
Therefore, washout was investigated under standardized ventilation
of a test lung. Washout was best described by an exponential decay
function with three variables: [Concentration] = y0 + a*eb[Time].
3.1 | Assessment of different preparation
procedures and fresh gas flow rates
Washout times were faster when the circle system and ventilator
diaphragm were replaced (Table 2). Further analyzes were therefore
restricted to procedures 3-5 to identify the best (Table 3). Procedure
5 showed the lowest residual concentrations, especially during early
washout times (Figure 2). The influence of the fresh gas flow rate
after performing the best tested preparation (procedure 5) is shown
TABLE 1 Definition of preparation procedures
Procedure Exchanged parts of the ventilator circuit
1None
2Breathing tubes/bag, carbon dioxide absorber
3Breathing tubes/bag, carbon dioxide absorber, circle
system, ventilator diaphragm
4 Breathing tubes/bag, carbon dioxide absorber, circle
system, ventilator diaphragm, sample tube, and
water trap of the capnography
5Additional 10-minute flush between removal and
replacement of the same par ts as in procedure 4
Note: Circle system and ventilator diaphragm were replaced by
autoclaved part s. All other par ts were replaced by new parts. Humid
and moisture exchanger was changed in all procedures. W ith each
procedure, a new non-contaminated test lung was ventilated during the
measurement period.
4 
|
   MÜLLER-WIRT Z ET aL.
in Table 3. A prolonged washout was obser ved for both volatile an-
esthetics when lower fresh gas flows were used (Figure 3). Even
after 100 0 minutes, some residual volatile anesthetic remained.
3.2 | Assessment of activated charcoal filters
All applications of activated charcoal filters reduced and maintained
residual concentrations of volatile anesthetics <5 ppm (= 500 0 ppb)
for 24 hours immediately after filter placement (within a maximum
of 30 seconds after placement). No volatile anesthetic was detect-
able for 24 hours when preparation procedure 5 was combined with
activated charcoal filters at the inspiratory and expiratory limb of the
workstation. Carrying out manufacturer's recommendations, desflu-
rane concentrations ranged from 0.9 to 2 ppb (0.0009 to 0.002 ppm)
and sevoflurane concentrations were below the limit of detection
(<2.2 ppb, 0.0022 ppm) for 24 hours. Even a single filter at the y-
piece of the breathing tubes with no other changes than the heat and
moisture filter reduced desflurane concentrations to a range from 1
to 1.8 ppb (0.001 to 0.0018 ppm), and sevoflurane concentrations
to a range from 2.2 to 5.6 ppb (0.0 022 to 0.0056 ppm) for 24 hours.
3.3 | Assessment of trace concentrations emitted by
different parts of the workstation
The fresh gas hose emitted residual concentrations of 1 ppb
(0.001 ppm) desflurane and 6.7 ppb (0.0067 ppm) sevoflurane. The
ventilator diaphragm emitted 0.9 ppb (0.0009 ppm) desflurane and
5.1 ppb (0.0051 ppm) sevoflurane. Residual concentrations in the
inspiratory limb of the circle system were 0.9 ppb (0.0 009 ppm) of
desflurane and below the limit of quantification for sevoflurane.
4 | DISCUSSION
4.1 | Assessment of different preparation
procedures and fresh gas flow rates
All preparation procedures that included a change of circle system
and ventilator diaphragm resulted in residual concentrations <5 ppm
for either anesthetic immediately after preparation (within a maxi-
mum of 30 seconds after preparation). Washout was faster with an
additional 10-minute flushing period between removal and reas-
sembly of all exchangeable par ts of the ventilator circuit. Our results
are consistent with Crawford et al who also showed that replacing
circle system and ventilator diaphragm markedly reduced residual
concentrations.8
Prinzha use n et al reported much longer me an wa sho ut times for
sevoflurane, needing 65 minutes to reach concentrations <5 ppm.9
The key distinction appears to be that Prinzhausen et al did not
TABLE 2 Washout times to reach concentrations <5 ppm
(5000 ppb)
Procedure
Time to [desflurane]
<5 ppm in min
Time to
[sevoflurane]
<5 ppm in min
1115 ± 30 (95-150) 107 ± 20 (85-125)
2103 ± 19 (90-125) 110 ± 20 (90-130)
33 ± 3 (0-5) 3 ± 3 (0-5)
4 3 ± 3 (0-5) 3 ± 3 (0-5)
50 ± 0 (0) 0 ± 0 (0)
Note: Data presented as means ± SDs (minimum-maximum). Each
procedure was per formed three times.
Desflurane Sevoflurane
Comparison of preparation procedures
Flow [L/min] 18
Procedure 345 3 45
10 min 383 ± 41* 320 ± 42* 215 ± 32 366 ± 141 374 ± 134 268 ± 63
100 min 214 ± 92 244 ± 30* 70 ± 6 112 ± 32 108 ± 24 75 ± 42
1000 min 28 ± 11* 22 ± 6 6 ± 2 8 ± 2 9 ± 2 7 ± 1
Comparison of different fresh gas flow rates
Procedure 5
Flow [L/min] 1 5 10 1 5 10
10 min 2661 916 141 6707 1658 204
100 min 2297 345 72 5653 14 5 89
1000 min 72 41 13 3 5 5
Note: The upper part of the table compares different preparation procedures. Procedure 5 was
identif ied to lead to the lowest residual concentrations of both volatile anesthetics. The lower part
of the table shows the influence of different fresh gas flow rates on washout after performing
procedure 5. *P < .05 vs procedure 5, one-way ANOVA, multiple comparisons Bonferroni
corrected. Dat a presented as means ± SDs. Values are given in ppb (1 ppb = 0.001 ppm).
TABLE 3 Residual concentrations
of desflurane and sevoflurane 10, 100
and 1000 min after preparation of the
workstation (Draeger Primus)
  
|
 5
MÜLLER-WIRT Z ET aL.
perform an exchange of the ventilators diaphragm during prepara-
tion. Cottron et al also report long washout times for sevoflurane
at a median of 42 minutes to reach concentrations below 5 ppm.7
Fresh gas flow was identical with our approach at 18 L /minute, but
the ventilators diaphragm was apparently unchanged. Available
data therefore suggest s that replacing all exchangeable parts of
the ventilator circuit is critical to speed washout. Our results fur-
ther show that additional 10 minutes of flushing between part re-
moval and reassembly further reduces residual volatile anesthetic
concentrations.
Washout after the best preparation was considerably faster
with a fresh gas flow of 10 L/minute than with 1 or 5 L/minute,
but increasing flow to 18 L/minute did not further speed washout.
We thus recommend using a fresh gas flow of 10 L/minute after
preparing the machine. An alternative strategy is to use a high gas
flow such as 10 L/minute until presumably safe concentrations
are reached, and then continue with a lower flow. However, pre-
vious studies detected a significant rebound in the concentration
after changing to low flow rates.8 ,9 A fresh gas flow of 10 L/min-
ute should thus be used for washout, and then maintained during
anesthesia.
4.2 | Assessment of activated charcoal filters
Activated charcoal filters immediately reduced residual volatile
anesthetic concentrations below 5 ppm (within a maximum of
FIGURE 2 A and B, Washout curves for desflurane (top, A)
and sevoflurane (bottom, B) following preparation procedures 3-5
(1 ppb = 0.001 ppm). Procedure 3: exchange of breathing tubes/
bag, carbon dioxide absorber, circle system, ventilator diaphragm;
procedure 4: exchange of breathing tubes/bag, carbon dioxide
absorber, circle system, ventilator diaphragm, sample tube and
water trap of the capnography; procedure 5: additional 10-min
flush bet ween removal and replacement of the same parts as in
procedure 4. Nonlinear regression was performed using the mean
values of the three measurement runs of each procedure. The
coefficient of determination (R2) describes the fit of the mean
values and the respective regression model [Colour figure can be
viewed at wileyonlinelibrar y.com]
FIGURE 3 A and B, Washout curves for desflurane (top,
A) and sevoflurane (bottom, B) following the best tested
preparation procedure (5) with 1, 5, and 10 L/min fresh gas flow
(1 ppb = 0.001 ppm). Each fresh gas flow rate was tested once.
Procedure 5:10-min flush between removal and replacement
of breathing tubes/bag, carbon dioxide absorber, circle system,
ventilator diaphragm, sample tube, and water trap of the
capnography. Nonlinear regression was performed to obtain
washout curves. The coefficient of determination (R2) describes the
fit of the measurement values and the respective regression model
[Colour figure can be viewed at wileyonlinelibrary.com]
6 
|
   MÜLLER-WIRT Z ET aL.
30 secon ds) and remained the m below 5 ppm for 24 ho ur s. Volatile
anesthetics were no longer detectable, even at parts-per-billion
concentrations when optimal workstation preparation was com-
bined with two activated charcoal filters. Our results are generally
co ns iste nt Ne ira et al who sho we d that th e com bin ati o n of Dr aeger
Zeus workstation preparation and charcoal filters was more ef-
fective than workstation preparation alone.14 The first study that
used FDA-approved activated charcoal f ilters reported an immedi-
ate reduc tion of volatile anesthetics within 2 minutes and concen-
trations remaining below 5 ppm for 60 minutes.11 Further studies
showed the reduction of residual concentrations below 5 ppm by
filter placement over 1212 and even up to 24 hours.15 We extend
previous results by showing that the application of a single acti-
vated charcoal filter at the Y-piece was as ef fective as the recom-
mended use which includes replacement of breathing tubes and
bag and the placement of two filters at inspiratory and expiratory
limb of the circle system. Taken altogether, every use of activated
charcoal filters that we assessed maintained residual concentra-
tions below 5 ppm for at least 24 hours. Positioning a single filter
at the y-piece appears to be perfectly effective—and is both fast
and inexpensive.
4.3 | Assessment of trace concentrations emitted by
different parts of the workstation
Optimal preparation and flushing massively reduced emission of
anesthetics, but residual concentrations remained detectable even
after 16 hours of flushing. The reason appears to be that non-ex-
changeable and autoclaved components continue to release trace
concentrations of volatile anesthetics. The fresh gas hose emitted
the highest concentrations, presumably due to its strong exposure
to volatile anesthetics, as it connects vaporizers to the circle sys-
tem. While autoclaving helped, it did not fully eliminate trace con-
centrations. Both, circle system and ventilator diaphragm emitted
desflurane and sevoflurane. It seems unlikely that parts-per-billion
residual anesthetic concentrations trigger malignant hyperthermia.
But to totally avoid exposure to volatile anesthetics, use of acti-
vated charcoal filters or a never-exposed “vapor-free” workstation
is necessary.
5 | CONCLUSION
Optimal preparation of a Draeger Primus workstation for patients
susceptible to malignant hyperthermia differs—with the replace-
ment of workstation components for elective and the use of acti-
vated charcoal filters for emergency cases. The best preparation
procedure includes a 10-minute flush ≥10 L/minute between re-
moval and reassembly of all parts of the ventilator circuit. In case
of emergencies, when malignant hyperthermia is suspected or ur-
gent anesthesia for susceptible patients is indicated, we recom-
mend using an activated charcoal filter. The first option (intended
use) includes the replacement of breathing tubes and bag, and
insertion of two activated charcoal filters on the inspiratory and
expiratory limbs. Alternatively, the placement of a single activated
charcoal filter at the y-piece is fast, inexpensive, and equally ef-
fective—but an of f-label use. Workstation preparation or filter use
should be followed by a fresh gas flow of 10 L/minute during the
subsequent procedure. Finally, the very lowest concentrations will
be obtained when machine preparation and activated charcoal
filters are combined, or by using a workstation never exposed to
volatile anesthetics.
ACKNOWLEDGEMENTS
This study contains data taken from the thesis presented by Christine
Godsch as par t of the requirement s for the obtention of the degree
“Doctor of Medicine” at Saarland University Medical Center and
Saarland University Faculty of Medicine.
CONFLICT OF INTEREST
The authors have no conflicts of interest.
ORCID
Lukas M. Müller-Wirtz https://orcid.org/0000-0002-7984-1798
REFERENCES
1. Met terlein T, Schuster F, Graf BM, Anetseder M . Malignant hyper-
thermia. Anaesthesist. 2014;63:908-918.
2. Wedel DJ, Gammel SA, Milde JH, Iaizzo PA. Delayed onset of
malignant hyperthermia induced by isoflurane and desflurane
compared with halothane in susceptible swine. Anesthesiology.
1993;78:113 8-1144.
3. Wedel DJ, Iaizzo PA, Milde JH. Desflurane is a trigger of ma-
lignant hyperthermia in susceptible swine. Anesthesiolog y.
1991;74:508-512.
4. Malignant Hyper thermia Association of the United States (MHAUS).
https://www.mhaus.org/
5. European Malignant Hyperthermia Group (emhg). ht tps://www.
emhg.org/
6. Maccani RM, Wedel DJ, Kor TM, Joyner MJ, Johnson MEHB. The
effec t of trace halothane exposure on triggering malignant hyper-
thermia in susceptible swine. Anesth Analg. 1996;82:S287.
7. Cot tron N, Larcher C, Sommet A, et al. The sevoflurane wash-
out profile of seven recent anesthesia workstations for malig-
nant hyperthermia-susceptible adults and infants. Anesth Analg.
20 14; 11 9:6 7-75.
8. Crawford MW, Prinzhausen H, Petroz GC. Accelerating the wash-
out of inhalational anesthetics from the Dräger Primus anes-
thetic workstation: effect of exchangeable internal components.
Anesthesiolog y. 2007;106:289-294.
9. Prinzhausen H, Crawford MW, O'Rourke J, Petroz GC. Preparation
of the Dräger Primus anesthetic machine for malignant hyperther-
mia-susceptible patients. Can J Anaesth. 20 06;53:885-890.
10. Kunze N, Weigel C , Vautz W, et al. Multi-capillary column-ion
mobilit y spectrometry (MCC-IMS) as a new method for the quan-
tification of occupational exposure to sevoflurane in anaesthesia
workplaces: an observational feasibility study. J Occup Med Toxicol.
20 15;1 0 :1-9.
11. Birgenheier N, Stoker R, Westenskow D, Orr J. Activated charcoal
effectively removes inhaled anesthetics from modern anesthesia
machines. Anesth Analg. 2011;112:1363-1370.
  
|
 7
MÜLLER-WIRT Z ET aL.
12. Bilmen JG, Gillies RL. Clarifying the role of activated charcoal
filters in preparing an anaesthetic workstation for malignant
hyperthermia-susceptible patients. Anaesth Intensive Care.
2014;42:51-58.
13. Maurer F, Walter L, Geiger M, et al. Calibration and validation of a
MCC/IMS prototype for exhaled propofol online measurement. J
Pharm Biomed Anal. 2017;145:293-297.
14. Neira VM, Al Madhoun W, Ghaffari K, Barrowman N, Berrigan P,
Splinter W. Efficacy of Malignant Hyper thermia Association of the
United States-recommended methods of preparation for malignant
hyperthermia-susceptible patients using Dräger Zeus anesthesia
workstations and associated costs. Anesth Analg. 2019;129:74-83.
15. Thoben C, Dennhardt N, Krauß T, et al. Preparation of anaesthesia
workstation for trigger-free anaesthesia: an observational labora-
tory study. Eur J Anaesthesiol. 2019;36:851-856.
How to cite this article: Müller-Wirtz LM, Godsch C, Sessler
DI, Volk T, Kreuer S, Hüppe T. Residual volatile anesthetics
after workstation preparation and activated charcoal
filtration. Acta Anaesthesiol Scand. 2020;00:1–7. ht t p s : //d oi .
org /10.1111/aas.13571
... Müller-Wirtz et al. reported that activated charcoal filters immediately reduced and maintained residual concentrations < 5 ppm v . Following removal of the ventilator circuit a flushing period of 10 min was found to be sufficient and a flow rate of 10 L min −1 was equally effective to a flow rate of 18 L min −1 to reduce residual concentrations < 5 ppm v [14]. Similar to our findings, Thoben et al. observed in their GC-IMS measurements a rapid decline of sevoflurane concentrations below threshold following the insertion of activated charcoal filters, but a 0.5 L min −1 FGF was needed to keep the concentration below 5 ppm v [11]. ...
... Müller-Wirtz et al. also observed traces of volatile anesthetics being emitted from the fresh gas hose, the circle system, and the ventilator diaphragm [14]. Conventional anesthesia workstations are more complex. ...
Article
Full-text available
Purpose A bench study to assess the elimination of sevoflurane from an anesthetic workstation using three different processing methods. Methods Sevoflurane concentrations from samples of the inspiratory breathing hose and air samples from within the investigation room were assessed during predetermined flush out intervals using Gas Chromatography-Ion Mobility Spectrometry. The primary objective was to determine the time to reach concentrations below 5 ppm v . Results Reduction of sevoflurane volume concentrations below a threshold of 5 ppm v was achieved within the first minute after removal of the vaporizer and the complete exchange of the soda and the breathing system and within the 15 min measurement interval after inclusion of two activated charcoal filters without a 90 s of flushing and without changing of the breathing hoses as required by the manufacturer. Conclusions Complete removal of the vaporizer and an exchange of the soda and the ventilation unit most quickly reduced sevoflurane concentrations, but the total processing interval may exceed 30 min. Inserted activated charcoal filters without a previous 90 s of flushing and without changing the breathing hoses followed by flushing only with raised fresh gas flow allow ventilation below trigger threshold to be reached within due time.
... Des Weiteren wird die IMS für die Überwachung medizinischer Biomarker [11][12][13], in die Lebensmittelsicherheit [14][15][16] sowie jüngst für die Analyse von Biogas genutzt [17]. Im medizinischen Bereich kommt die IMS auch zur Bestimmung der Arbeitsplatzkonzentration volatiler Anästhesiegase in Aufwachräumen zum Einsatz [18; 19], hier insbesondere zur Quantifizierung der Restkonzentration volatiler Anästhetika bei "triggerfreier" Allgemeinanästhesie [20][21][22][23]. ...
... Water quality management for aquaculture purposes is crucial because water serves as the living medium for aquatic organisms. One method used to maintain water quality in cultivation media is through the use of filters [5]. Filtration technology is also widely employed to capture and concentrate virus pathogens transmitted through water [6], from samples of drinking water, the environment, recreation, or wastewater [7,8]. ...
Article
Full-text available
Bacterial cellulose membranes find extensive applications in industries involving water purification, wastewater treatment, and biomedical uses. Nevertheless, prevailing membranes suffer from drawbacks like water flow hindrances and fouling susceptibility. Hence, the pressing need for more efficient and robust BC membranes. This study aims to assess the impact of a hybrid treatment involving Copper Oxide nanoparticles (CuO-NPs) and Graphene Oxide (GO) on bacterial nanocellulose membranes. The research employed two treatments: (1) control (BNCA), and (2) Bacterial cellulose infused with 0.5 wt% CuO-NPs/GO. The nanocellulose production involved a high-pressure homogenizer, followed by acetate nanocellulose synthesis and nanocomposite membrane functionalization with CuO nanoparticles. SEM, FTIR, and XRD analyses characterized the membranes. Successfully formed seaweed-derived bacterial cellulose had a thickness of 1-3 cm. Characterization showed it belonged to Cellulose type I with a crystalline degree ranging from 82.3% to 83.1%. FTIR analysis of dry BNCA membranes indicated changes in transmittance at 1738, 1554, and 764 cm-1 due to CuO-NPs/GO addition, altering the O-H bond in bacterial cellulose. Based on the results of the above research, it is evident that the Membrane Reinforced with CuO-NPs/Graphene Oxide has been successfully developed and holds potential as a water nanofiltration system.
... In unserer Versuchsreihe wurde der Aktivkohlefilter allerdings am Y-Stück platziert. Dies führte zur Erweiterung von früheren Studienergebnissen, da die Anwendung eines einzelnen Aktivkohlefilters am Y-Stück genauso effektiv war, wie die empfohlene Verwendung, die den Austausch von Atemschläuchen und -beutel, sowie die Platzierung von zwei Filtern am inspiratorischen und exspiratorischen Schenkel des Kreisteils umfasste[50].Sakata and Orr [63], stellvertretend für die Herstellerfirma der untersuchten Aktivkohlefilter, merkten jedoch als Reaktion auf die Publikation der vorliegenden Studie an, dass während einer malignen Hyperthermiekrise der Patient, die Hauptquelle für Restemissionen von volatilen Anästhetika darstellt. Durch die Positionierung des Aktivkohlefilters am Y-Stück käme es in diesem Setting zur vermehrten Reflexion der Inhalationsanästhetika. Da die Reflexion flüchtiger Anästhetika durch Vapor-Clean TM -Filter nicht Teil dieser ursprünglichen Untersuchung war, führten wir diesbezüglich eine Folgeuntersuchung durch. ...
... An integration of carbon dioxide or flow triggered sampling could help sample isolated exhaled gas and thus increase the proportion of alveolar gas in breath samples [36]. Furthermore, activated charcoal filters, originally designed to eliminate residual volatile anesthetics emitted from anesthesia workstations, are now available [37]. Using an activated charcoal filter between the anesthesia machine and the inspiratory limb of the rebreathing circuit would presumably eliminate contamination from within the machine. ...
Article
Full-text available
Exhaled aliphatic aldehydes were proposed as non‐invasive biomarkers to detect in‐ creased lipid peroxidation in various diseases. As a prelude to clinical application of the multicapil‐ lary column–ion mobility spectrometry for the evaluation of aldehyde exhalation, we, therefore: (1) identified the most abundant volatile aliphatic aldehydes originating from in vitro oxidation of var‐ ious polyunsaturated fatty acids; (2) evaluated emittance of aldehydes from plastic parts of the breathing circuit; (3) conducted a pilot study for in vivo quantification of exhaled aldehydes in me‐ chanically ventilated patients. Pentanal, hexanal, heptanal, and nonanal were quantifiable in the headspace of oxidizing polyunsaturated fatty acids, with pentanal and hexanal predominating. Plastic parts of the breathing circuit emitted hexanal, octanal, nonanal, and decanal, whereby nona‐ nal and decanal were ubiquitous and pentanal or heptanal not being detected. Only pentanal was quantifiable in breath of mechanically ventilated surgical patients with a mean exhaled concentra‐ tion of 13 ± 5 ppb. An explorative analysis suggested that pentanal exhalation is associated with mechanical power—a measure for the invasiveness of mechanical ventilation. In conclusion, ex‐ haled pentanal is a promising non‐invasive biomarker for lipid peroxidation inducing pathologies, and should be evaluated in future clinical studies, particularly for detection of lung injury.
... [15] Instructions of the washout time were at least 20 minutes with a fresh gas flow rate of more than 10 L/min. [16,17] So, we can do this wash out procedure during the pre-anesthesia checkout procedures routinely. ...
Article
Full-text available
Rationale: Sevoflurane-induced seizures are most often caused by high concentrations of sevoflurane during anesthesia induction. However, in this case, we found a rare case of seizure-like movements caused by residual sevoflurane inside the anesthesia machine. Therefore, we propose that the detection of residual anesthesia-inhaled drugs should be included in pre-anesthesia checkout procedures. Patient concerns: An 11-year-old girl with a history of epilepsy was scheduled for emergency appendectomy under general anesthesia. The patient presented with seizure-like movements caused by residual sevoflurane inside the anesthesia machine after pre-oxygenation during rapid sequence induction. Diagnoses: Based on the clinical presentation and previous history of seizures, sevoflurane-induced seizures were diagnosed. Interventions: A washout procedure was performed by turning the oxygen flow up to 10L/min to wash out the residual sevoflurane from the anesthesia machine. Outcomes: The seizures ceased spontaneously, and the vital signs of the patient were stable during the washout procedure. Rapid sequence anesthesia induction and total intravenous anesthesia maintenance were uneventful. Surgery was performed as planned, and there were no postoperative problems. The patient was discharged after 4 days without complications and was well on follow-up. Lessons: The check-up procedure of residual anesthesia-inhaled drugs inside the anesthesia machine should be included in the checkout design guidelines, or else the washout procedure should be performed in the pre-anesthesia checkout procedures.
Chapter
Malignant hyperthermia (MH) is a pharmacogenetic and potentially fatal disease. Susceptible patients when exposed to the triggering agents (halogenated volatile anaesthetics, succinylcholine, extreme exercise) can develop the disease. The clinical presentation of the MH crisis results from exacerbated cellular hypermetabolism and is extremely varied, ranging from muscle contracture to cardiorespiratory arrest. Patients may experience muscle complaints in daily life, such as myalgia, cramps or intolerance to physical exertion. Currently, the recommended treatment for the crisis involves intensive support and administration of dantrolene. Correct diagnosis and treatment performed early ensures a high survival rate. For patients known to be susceptible to MH, it is possible to perform the appropriate preparation of the anaesthesia station and the operating room to reduce the contamination of the environment with anaesthetic gases, thus performing a safer surgical-anaesthetic procedure for the patient at risk for developing the disease.
Article
Abstract: The European Malignant Hyperthermia Group (EMHG) has published consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients. This was realized by the AGREE checklist (appraisal of guidelines, research and evaluation). After search and analysis of the existing literature a consensus was generated using a modified Delphi process. Preparation of the anesthetic machines for trigger-free ventilation can be achieved using separate workstations which had never contact to volatile anesthetics, by preparing the machines according to manufacturer instructions or using active charcoal filters to clear the machines from trace gas concentrations. The later has the advantage of a standardized procedure which is not varying between the manufacturers of the anesthetic workstations. - Zusammenfassung: Die Europäische Maligne Hyperthermie Gruppe (EMHG) hat eine Leitlinie zum perioperativen Management von Patienten mit vermutetem oder gesichertem Risiko für Maligne Hyperthermie (MH) erarbeitet. Der Prozess zur Erstellung der Leitlinien richtete sich nach der AGREE (appraisal of guidelines, research and evaluation) Checkliste [1]. Nach Auswertung der verfügbaren Literatur wurden Konsensus Empfehlungen mit Hilfe eines modifizierten Delphi Prozess formuliert. Zur Vorbereitung eines triggerfreien Narkosegerätes werden verschiedene gleichwertige Optionen empfohlen: Neben der Vorhaltung eines separaten Narkosegerätes, welches nie Kontakt zu volatilen Anästhetika hatten, können als klassische Vorbereitung die Narkosegeräte nach Herstellerangaben „gespült“ werden. Als jüngere Methode, um Restgaskonzentrationen aus den Geräten zu entfernen, kommt die Verwendung spezieller Aktivkohlefilter in Frage, die den Vorteil eines einheitlichen Geräte- und Hersteller-unabhängigen Vorgehens beinhaltet.
Article
Malignant hyperthermia is a potentially fatal condition, in which genetically predisposed individuals develop a hypermetabolic reaction to potent inhalation anaesthetics or succinylcholine. Because of the rarity of malignant hyperthermia and ethical limitations, there is no evidence from interventional trials to inform the optimal perioperative management of patients known or suspected with malignant hyperthermia who present for surgery. Furthermore, as the concentrations of residual volatile anaesthetics that might trigger a malignant hyperthermia crisis are unknown and manufacturers' instructions differ considerably, there are uncertainties about how individual anaesthetic machines or workstations need to be prepared to avoid inadvertent exposure of susceptible patients to trigger anaesthetic drugs. The present guidelines are intended to bundle the available knowledge about perioperative management of malignant hyperthermia-susceptible patients and the preparation of anaesthesia workstations. The latter aspect includes guidance on the use of activated charcoal filters. The guidelines were developed by members of the European Malignant Hyperthermia Group, and they are based on evaluation of the available literature and a formal consensus process. The most crucial recommendation is that malignant hyperthermia-susceptible patients should receive anaesthesia that is free of triggering agents. Providing that this can be achieved, other key recommendations include avoidance of prophylactic administration of dantrolene; that preoperative management, intraoperative monitoring, and care in the PACU are unaltered by malignant hyperthermia susceptibility; and that malignant hyperthermia patients may be anaesthetised in an outpatient setting.
Article
Full-text available
Background: The objective of this study was to assess the efficacy and cost of Malignant Hyperthermia Association of the United States-recommended methods for preparing Dräger Zeus anesthesia workstations (AWSs) for the malignant hyperthermia-susceptible patient. Methods: We studied washout profiles of sevoflurane, isoflurane, and desflurane in 3 Zeus AWS following 3 preparation methods. AWS was primed with 1.2 minimum alveolar concentration anesthetic for 2 hours using 2 L/min fresh gas flow, 500 mL tidal volume, and 12/min respiratory rate. Two phases of washout were performed: high flow (10 L/min) until anesthetic concentration was <5 parts per million (ppm) for 20 minutes and then low flow (3 L/min) for 20 minutes to identify the rebound effect. Preparation methods are as follows: method 1 (M1), changing disposables (breathing circuit, soda lime, CO2 line, and water traps); method 2 (M2), M1 plus replacing the breathing system with an autoclaved one; and method 3 (M3), M1 plus mounting 2 activated charcoal filters on respiratory limbs. Primary outcomes are as follows: time to obtain anesthetic concentration <5 ppm in the high-flow phase, peak anesthetic concentrations in the low-flow phase, and for M3 only, peak anesthetic concentration after 70 minutes of low-flow phase, when activated charcoal filters are removed. Secondary outcomes are as follows: cost analysis of time and resources to obtain anesthetic concentration <5 ppm in each method and a vapor-free Zeus AWS. Sensitivity analyses were performed using alternative assumptions regarding the costs and the malignant hyperthermia-susceptible caseload per year. Results: Primary outcomes were as follows: M3 instantaneously decreased anesthetic concentration to <1 ppm with minimal impact of low-flow phase. M1 (median, 88 minutes; 95% confidence interval [CI], 69-112 minutes) was greater than M2 (median, 11 minutes; 95% CI, 9-15 minutes). Means of peak rebound anesthetic concentrations in M1, M2, and M3 were 15, 6, and 1 ppm, respectively (P < .001). Anesthetic concentration increased 33-fold (95% CI, 21-50) after removing charcoal filters (from 0.7 to 20 ppm). The choice of anesthetic agents did not impact the results. Secondary outcomes were as follows: M3 was the lowest cost when the cost of lost operating room (OR) time due to washout was included, and M1 was the lowest cost when it was not included. When the cost of lost OR time due to washout was considered the estimated cost/case of M3 was US 360(M1,US360 (M1, US 2670; M2, US 969;anda"vaporfree"ZeusAWSwasUS969; and a "vapor-free" Zeus AWS was US 930). The OR time and equipment costs represent the largest differentiators among the methods. Conclusions: Institutions in which demand for OR time has exceeded capacity should consider M3, and institutions with surplus OR capacity should consider M1.
Article
Full-text available
Occupational exposure to sevoflurane has the potential to cause health damage in hospital personnel. Workplace contamination with the substance mostly is assessed by using photoacoustic infrared spectrometry with detection limits of 10 ppbv. Multi-capillary column-ion mobility spectrometry (MCC-IMS) could be an alternative technology for the quantification of sevoflurane in the room air and could be even more accurate because of potentially lower detection limits. The aim of this study was to test the hypothesis that MCC-IMS is able to detect and monitor very low concentrations of sevoflurane (<10 ppbv) and to evaluate the exposure of hospital personnel to sevoflurane during paediatric anaesthesia and in the post anaesthesia care unit (PACU). A MCC-IMS device was calibrated to several concentrations of sevoflurane and limits of detection (LOD) and quantification (LOQ) were calculated. Sevoflurane exposure of hospital personnel was measured at two anaesthesia workplaces and time-weighted average (TWA) values were calculated. The LOD was 0.0068 ppbv and the LOQ was 0.0189 ppbv. During paediatric anaesthesia the mean sevoflurane concentration was 46.9 ppbv (8.0 - 314.7 ppbv) with TWA values between 5.8 and 45.7 ppbv. In the PACU the mean sevoflurane concentration was 27.9 ppbv (8.0 - 170.2 ppbv) and TWA values reached from 8.3 to 45.1 ppbv. MCC-IMS shows a significantly lower LOD and LOQ than comparable methods. It is a reliable technology for monitoring sevoflurane concentrations at anaesthesia workplaces and has a particular strength in quantifying low-level contaminations of sevoflurane. The exposure of the personnel working in these areas did not exceed recommended limits and therefore adverse health effects are unlikely.
Article
Full-text available
Malignant hyperthermia (MH) is a life-threatening condition caused by exposure of susceptible individuals to volatile anaesthetics or suxamethonium. MH-susceptible individuals must avoid exposure to these drugs, so accurate and reproducible processes to remove residual anaesthetic agents from anaesthetic workstations are required. Activated charcoal filters (ACFs) have been used for this purpose. ACFs can reduce the time for preparing an anaesthetic workstation for MH patients. Currently, the only commercially available ACFs are the Vapor-Cleantrade;(Dynasthetics,SaltLakeCity,UT,USA)filterswhichretailatapproximatelyAUDtrade; (Dynasthetics, Salt Lake City, UT, USA) filters which retail at approximately AUD130 per set of two, both of which are to be used in a single anaesthetic. Anaesthetic workstations were saturated with anaesthetic vapours and connected to a Miran ambient air analyser (SapphRe XL, ThermoScientific, Waltham, MA, USA) to measure vapour concentration. Various scenarios were tested in order to determine the most economical configurations of machine flushing, component change and activated charcoal filter use. We found that placement of filters in an unprepared, saturated circuit was insufficient to safely prepare an anaesthetic workstation. Following flushing of the anaesthetic workstation with high-flow oxygen for 90 seconds, a circuit and soda lime canister change and the placement of an ACF on the inspiratory limb, we were able to safely prepare a workstation in less than three minutes. A single filter on the inspiratory limb was able to maintain a clean circuit for 12 hours, with gas flows dropped from 10 lpm to 3 lpm after 90 minutes or removal of the filter after 90 minutes if high gas flows were maintained.
Article
Background: Trigger-free anaesthesia is required for patients who are susceptible to malignant hyperthermia. Therefore, all trace of volatile anaesthetics should be removed from anaesthetic machines before induction of anaesthesia. Because the washout procedure is time consuming, activated charcoal filters (ACFs) have been introduced, but never tested under minimal flow conditions. Objective(s): The current study aims to investigate performance of ACFs during long duration (24 h) simulated ventilation. Design: A bench study. Setting: A Primus anaesthesia machine (Dräger) was contaminated with either 4% sevoflurane or 8% desflurane by ventilating a test lung for 90 min. The machine was briefly flushed according to manufacturer instructions, ACFs were inserted and a test lung was ventilated in a 24 h test. Trace gas concentrations were measured using a closed gas loop high-resolution ion mobility spectrometer with gas chromatographic preseparation. During the experiment reduced fresh gas flows (FGFs) were tested. At the end of each experiment the ACFs were removed and the machine was set to standby for 10 min to test for residual contamination within the circuit. and then the ACFs were reconnected into the circuit to test their ability to continue removing volatile anaesthetics (functional test) from the gas. Control experiments were conducted without ACFs. Main outcome measures: Absolute concentrations of desflurane and sevoflurane. Results: The concentration of volatile anaesthetics dropped to less than 5 ppm (parts per million) following insertion of ACFs. In the desflurane experiments at least 1 l min FGF was needed to keep the concentration below an acceptable level (<5 ppm): 0.5 l min FGF was required in sevoflurane experiments. While ACFs in the sevoflurane tests passed the functional test after 24 h, ACFs in the desflurane tests failed. Conclusion: ACFs meet the requirements for trigger-free low flow (1 l min) ventilation over 24 h. Minimal flow (0.5 l min) ventilation may be possible for sevoflurane contaminated machines.
Article
Propofol is a commonly used intravenous general anesthetic. Multi-capillary column (MCC) coupled Ion-mobility spectrometry (IMS) can be used to quantify exhaled propofol, and thus estimate plasma drug concentration. Here, we present results of the calibration and analytical validation of a MCC/IMS pre-market prototype for propofol quantification in exhaled air. Calibration with a reference gas generator yielded an R² ≥ 0.99 with a linear array for the calibration curve from 0 − 20 ppbv. The limit of quantification was 0.3 ppbv and the limit of detection was 0.1 ppbv. The device is able to distinguish concentration differences > 0.5 ppbv for the concentration range between 2 − 4 ppbv and > 0.9 ppbv for the range between 28 − 30 ppbv. The imprecision at 20 ppbv is 11.3% whereas it is 3.5% at a concentration of 40 ppbv. The carry-over duration is 3 minutes. The MCC/IMS we tested provided online quantification of gaseous propofol over the clinically relevant range at measurement frequencies of one measurement each minute.
Article
Malignant hyperthermia (MH) is a rare hereditary, mostly subclinical myopathy. Trigger substances, such as volatile anesthetic agents and the depolarizing muscle relaxant succinylcholine can induce a potentially fatal metabolic increase in predisposed patients caused by a dysregulation of the myoplasmic calcium (Ca) concentration. Mutations in the dihydropyridine ryanodine receptor complex in combination with the trigger substances are responsible for an uncontrolled release of Ca from the sarcoplasmic reticulum. This leads to activation of the contractile apparatus and a massive increase in cellular energy production. Exhaustion of the cellular energy reserves ultimately results in local muscle cell destruction and subsequent cardiovascular failure. The clinical picture of MH episodes is very variable. Early symptoms are hypoxia, hypercapnia and cardiac arrhythmia whereas the body temperature rise, after which MH is named, often occurs later. Decisive for the course of MH episodes is a timely targeted therapy. Following introduction of the hydantoin derivative dantrolene, the previously high mortality of fulminant MH episodes could be reduced to well under 10 %. An MH predisposition can be detected using the invasive in vitro contracture test (IVCT) or mutation analysis. Few elaborate diagnostic procedures are in the developmental stage.
Article
Preoperative flushing of an anesthesia workstation is an alternative for preparation of the anesthesia workstation before use in malignant hyperthermia-susceptible patients (MHS). We studied in vitro, using a test lung, the washout profile of sevoflurane in 7 recent workstations during adult and, for the first time, pediatric ventilation patterns. Anesthesia workstations were first primed with 3% sevoflurane for 2 hours and then prepared according to the recommendations of the Malignant Hyperthermia Association of the United States. The flush was done with maximal fresh gas flow (FGF) with a minute ventilation equal to 600 mL × 15, to reach a sevoflurane concentration of <5 parts per million. After flush, 2 clinical situations were simulated in vitro to test the efficiency of preparation: decrease of FGF from max to 10 L/min, or decrease of minute ventilation to 50 mL × 30, to simulate the ventilation of an MHS infant. We report washout delays for MHS patients for previously studied workstations (Primus®, Avance®, and Zeus®) and more interestingly, for machines not previously tested (Felix®, Flow-I®, Perseus®, and Leon®). An increase of sevoflurane concentration was observed when decreasing FGF (except for flow-I® and Leon®) and during simulation of MHS infant ventilation (except for Felix®). This descriptive study strongly suggests that washout profiles may differ for each anesthesia workstation. We advise the use of maximal FGF during preparation and anesthesia. Required flushing times are longer when preparing an anesthesia workstation before providing anesthesia for MHS infants.
Article
If a malignant hyperthermia-susceptible patient is to receive an anesthetic, an anesthesia machine that has been used previously to deliver volatile anesthetics should be flushed with a high fresh gas flow. Conflicting results from previous studies recommend flush times that vary from 10 to 104 minutes. In a previously proposed alternative decontamination technique, other investigators placed an activated charcoal filter in the inspired limb of the breathing circuit. We placed activated charcoal filters on both the inspired and expired limbs of several contaminated anesthesia machines and measured the time needed to flush the machine so that the delivered concentrations of isoflurane, sevoflurane, and desflurane would be <5 parts per million (ppm). We next simulated the case for which malignant hyperthermia is diagnosed 90 minutes after induction of anesthesia and measured how well activated charcoal filters limit further exposure. Activated charcoal filters decrease the concentration of volatile anesthetic delivered by a contaminated machine to an acceptable level in <2 minutes. The concentrations remained well below 5 ppm for at least 60 minutes. When malignant hyperthermia is diagnosed after induction of anesthesia, we found that with charcoal filters in place, the current anesthesia machine may be used for at least 67 minutes before the inspired concentration exceeds 5 ppm. Activated charcoal filters provide an alternative approach to the 10 to 104 minutes of flushing that are normally required to prepare a machine that has been used previously to deliver a volatile anesthetic.
Article
Desflurane (difluoromethyl 1-fluoro 2,2,2-trifluoroethyl ether: CF2-H-O-CFH-CF3) is a potent inhalation anesthetic agent being investigated for possible clinical use. The authors examined the effects of this agent on normal swine and those from a special breeding program that were considered purebred for susceptibility to malignant hyperthermia (MH). Animals were exposed to 1 or 2 MAC or both doses of desflurane and observed for changes in end-tidal CO2, arterial blood gases, lactate, catecholamines, core temperature, blood pressure, and heart rate. All normal swine tolerated exposure to desflurane without clinical signs of MH, but significant changes in heart rate and blood pressure were noted. In contrast, of six MH susceptible swine tested, two had unequivocal MH reactions to deflurane, defined by significant increases of end-tidal CO2 (greater than 50 mmHg), an increase in PaCO2 (greater than 70 mmHg), a decrease in blood pH (less than 7.30), an increase in blood lactate concentration, and an increase in core temperature. Two other susceptible swine showed equivocal signs of MH but not until desflurane had been administered for 40-60 min. Finally, two other susceptible swine showed no signs of MH after 60 min of exposure to 2 MAC desflurane. These latter four animals all developed episodes of MH immediately after intravenous succinylcholine (2 mg/kg). The increased PaCO2, blood lactate concentrations, and temperature, and the decrease in pH induced by desflurane, were successfully treated with dantrolene and supportive measures. All surviving animals were biopsied 1 to 2 weeks after the exposure to desflurane for in vitro contracture testing to confirm MH susceptibility.(ABSTRACT TRUNCATED AT 250 WORDS)
Article
Desflurane (difluoromethyl 1-fluoro 2,2,2-trifluoroethyl ether) is a new inhalational anesthetic currently under investigation for use in humans. Recently, the authors showed that desflurane is a trigger of malignant hyperthermia (MH) in susceptible swine. To date, there has been no in vivo comparison of the relative ability of inhalational anesthetics to trigger MH. The effects of desflurane, isoflurane, and halothane on six MH-susceptible purebred and six MH-susceptible mixed-bred Pietrain swine were examined. The animals were exposed to 1 MAC and 2 MAC (if MH was not triggered after 1 MAC hour) doses of each of the three volatile anesthetics in random sequence at 7-10-day intervals and changes in end-tidal CO2, arterial blood gases, serum lactate, core and muscle temperature, blood pressure, and heart rate were measured. There was a statistical difference between anesthetics in the time required to trigger MH; halothane exposure resulted in the fastest onset of an MH episode (20 +/- 5 min), compared with isoflurane (48 +/- 24 min) and desflurane (65 +/- 28 min), both of which required significantly longer exposures. There was no statistical difference between the MH purebred and mixed-bred swine in the time required to trigger MH (defined as a PaCO2 of 70 mmHg) with a given agent, and time to triggering was also independent of the order of exposure to the three anesthetics. Malignant hyperthermia susceptibility was confirmed in ten surviving animals, by both in vivo succinylcholine challenge and in vitro contracture testing. Although all three volatile anesthetics triggered MH, exposure to halothane resulted in significantly shorter times to MH triggering when compared with desflurane and isoflurane.